ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Lumbar degenerative disease: association of serum complement levels with diagnosis, structural severity, and postoperative prognosis.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purposeThe clinical evaluation of lumbar degenerative disease (LDD) severity relies on symptoms and imaging, lacking biologically specific diagnostic markers. This study investigated the role of serum complements in LDD to assess their potential as diagnostic biomarkers, their correlation with anatomical stenosis, and their ability to predict postoperative recovery. We hypothesized that specific serum complement levels correlate with both structural severity and clinical outcomes.
methodsA prospective investigation was conducted on 82 patients with LDD and 90 healthy controls. To minimize selection bias, a 1:1 propensity score matching (PSM) was performed for age and gender, resulting in a matched cohort of 112 participants. Serum levels of C1q, C3, and C4 were compared, while CRP and ESR were screened to exclude systemic inflammation. Anatomical severity was quantified using the S1/S0 ratio (dural sac area ratio) on MRI. Pain intensity was evaluated via Visual Analogue Scale (VAS) scores; quality of life was appraised using ODI and Barthel scales. Surgical prognosis was defined by achieving the Minimal Clinically Important Difference (MCID, ΔVAS ≥ 1.6) at 2-month follow-up.
resultsSerum C1q levels were significantly higher in the LDD group compared to controls (184.62 vs. 156.51 g/L, P = 0.001), whereas C3 and C4 showed no significant difference. Baseline CRP and ESR levels were within normal ranges, confirming the specificity of complement activation. ROC analysis demonstrated that C1q effectively distinguished LDD patients (AUC = 0.688), with an optimal cut-off of 154.40 g/L. Serum C4 levels exhibited a significant inverse correlation with the S1/S0 ratio (β = -0.867, P = 0.004). Baseline C1q was an independent predictor of failing to achieve MCID (OR = 0.980, P = 0.010). Patients who did not attain MCID had significantly higher baseline C1q levels. The rate of achieving MCID was lower in the highest C1q quartile (Q4: 52.6%) compared to the lowest (Q1: 75.0%).
conclusionSerum C1q and C4 serve as dual biomarkers in LDD. C4 correlates with anatomical stenosis severity, while C1q predicts surgical prognosis. Integration of serum complement profiling and radiological imaging improves preoperative risk stratification and facilitates surgical decision-making.
Indexed as
Identifiers
42340436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.